Advertisement
AlphaTON Capital Corp. Common Stock

AlphaTON Capital Corp. Common Stock (ALP) Stock Overview

Explore AlphaTON Capital Corp. Common Stock’s financial performance, market position, analyst ratings, and future outlook.

ALPNASDAQ
HealthcareBiotechnology
$0.25
$0.01(4.23%)
U.S. Market opens in 59h 50m
Advertisement

AlphaTON Capital Corp. Common Stock (ALP)

Meyka AI Score

Z

Key Financials

Market Cap5.9M
P/E Ratio-0.03
EPS (TTM)$-8.01
ROE-9.25%
Fundamental Analysis

AI Price Forecasts

1 Month$0.19
3 Months$0.25
1 Year Target$0.00

ALP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AlphaTON Capital Corp. Common Stock (ALP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.35, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.03 and a market capitalization of 5.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.23%
5-Day Change
-3.75%
1-Month Change
-31.27%
3-Month Change
-27.46%
6-Month Change
-65.54%
Year-to-Date (YTD) Change
-58.53%
1-Year Change
-95.53%
3-Year Change
-99.66%
5-Year Change
-99.97%
All-Time (Max) Change
-99.98%

Contact Information

302 219 5556
Clarence Thomas Building, Road Town, NaN, VG1110

Company Facts

40 Employees
IPO DateJan 2, 2002
CountryVG
Actively Trading

Frequently Asked Questions